I agree. In my opinion, it appears that CD16 will
Post# of 148155
(Total Views: 439)
Posted On: 03/22/2021 1:11:09 PM
I agree. In my opinion, it appears that CD16 will not be necessary. CD12 will continue with open label extension, and no placebo arm or randomization necessary. This is the ideal solution, basically a phase 4 with data monitoring. To me that indicates that an EUA is imminent.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼